Healthpeak Properties Inc. logo

Healthpeak Properties Inc. (DOC)

Market Open
24 Jul, 16:57
NYSE NYSE
$
18. 98
-0.07
-0.39%
$
12.78B Market Cap
30.93 P/E Ratio
1.2% Div Yield
2,053,856 Volume
0.39 Eps
$ 19.05
Previous Close
Day Range
18.92 19.12
Year Range
16.64 23.26
Want to track DOC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 90 days
What's in the Cards for Healthpeak Properties This Earnings Season?

What's in the Cards for Healthpeak Properties This Earnings Season?

DOC's Q2 earnings are likely to benefit from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.

Zacks | 1 day ago
Healthpeak (DOC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Healthpeak (DOC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of Healthpeak (DOC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 3 days ago
Healthpeak's Valuation Disconnect: Strong Assets, Low Expectations

Healthpeak's Valuation Disconnect: Strong Assets, Low Expectations

Healthpeak Properties is strategically focused on Class A outpatient and life science real estate, benefiting from demographic tailwinds and supply constraints in key markets. The recent Physicians Realty Trust merger enhances scale, operational synergies, and defensibility, positioning Healthpeak for steady FFO growth as sector fundamentals improve. Despite high leverage and capital allocation risks, Healthpeak trades at a significant discount to historical valuation multiples, offering attractive long-term total return potential.

Seekingalpha | 1 week ago
Healthpeak Properties: Attractive Yield For Income-Oriented Investors

Healthpeak Properties: Attractive Yield For Income-Oriented Investors

Healthpeak Properties offers strong upside potential, driven by robust AFFO growth, merger synergies, and a well-covered 7% dividend yield. Recent earnings show double-digit revenue and AFFO growth, with management guiding for continued double-digit AFFO growth and solid same-store NOI in 2025. Share repurchases, a switch to monthly dividends, and a healthy balance sheet further support long-term price appreciation and income stability.

Seekingalpha | 2 weeks ago
Why Healthpeak (DOC) is a Top Momentum Stock for the Long-Term

Why Healthpeak (DOC) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 weeks ago
Healthpeak Offers An Attractive Dividend Yield With Room For Growth

Healthpeak Offers An Attractive Dividend Yield With Room For Growth

Healthpeak offers a nearly 7% yield, strong dividend coverage, and trades at a deep discount to private market value, making it a compelling buy. The merger with Physicians Realty Trust created a diversified, cost-efficient REIT with reliable income from medical offices and upside from labs and senior housing. Risks like soft lab demand and higher rates are cushioned by long leases, fixed debt, and strong outpatient/CCRC performance, ensuring dividend security.

Seekingalpha | 2 weeks ago
The Healthpeak Properties Dilemma: Merger Payoff Ahead, Or More Pain For Investors?

The Healthpeak Properties Dilemma: Merger Payoff Ahead, Or More Pain For Investors?

DOC is a hold—stock trades near lows, post-merger integration is ongoing, and the market isn't buying the growth story yet. Merger with Physicians Realty Trust brings scale and diversification, but organic growth is lacking and integration risks remain. Valuation isn't compelling: payout ratio is stretched, margins are middling, and peers offer better value or growth opportunities.

Seekingalpha | 3 weeks ago
Healthpeak: An Attractive Deal Here

Healthpeak: An Attractive Deal Here

Healthpeak Properties is trading at historically low valuations, offering a compelling 7% dividend yield with strong coverage and solid operating results. The REIT's diversified portfolio, consistent NOI growth, and defensive healthcare focus provide stability and resilience against macroeconomic shocks. Insider buying and share repurchases signal management's confidence in the stock's undervaluation and future upside potential.

Seekingalpha | 3 weeks ago
5 Goldman Sachs S&P 500 Dividend Picks With the Highest Prospective Risk-Adjusted Returns

5 Goldman Sachs S&P 500 Dividend Picks With the Highest Prospective Risk-Adjusted Returns

Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.

247wallst | 1 month ago
Dividends Under $60: Don't Miss This 7.1% High-Yield Stock

Dividends Under $60: Don't Miss This 7.1% High-Yield Stock

A dividend stock with 7%-plus yields and solid upside potential. The downside risk is also limited at current prices.

247wallst | 1 month ago
5 Lessons For My 5 Kids

5 Lessons For My 5 Kids

Fifteen years of investing and writing taught me that humility, perseverance, and financial literacy are essential for long-term success. Avoid market timing and emotional investing; focus on time in the market, sound fundamentals, and disciplined research-based decisions. Steer clear of high-yield, speculative REITs; prioritize blue-chip REITs with reliable income and growth prospects for wealth building.

Seekingalpha | 1 month ago
3 Dividend Stocks That Could Double Your Monthly Income

3 Dividend Stocks That Could Double Your Monthly Income

Dividend stocks are worth loading up on, as significant uncertainty is still ahead.

247wallst | 2 months ago
Loading...
Load More